99 related articles for article (PubMed ID: 6683591)
1. Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma.
Engstrom PF; Lavin PT; Klaassen DJ
Cancer Treat Rep; 1983; 67(7-8):713-5. PubMed ID: 6683591
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.
Ravry MJ; Moore MR; Omura GA; Esseese I; Bartolucci A
Cancer Treat Rep; 1985 Dec; 69(12):1457-8. PubMed ID: 4075322
[No Abstract] [Full Text] [Related]
3. [Antiblastic chemotherapy in esophageal cancer].
Cartei G
Radiol Med; 1983; 69(7-8):597-600. PubMed ID: 6322245
[No Abstract] [Full Text] [Related]
4. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP
Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171
[TBL] [Abstract][Full Text] [Related]
5. [Mitomycin C and cisplatin as single agents in the second-line treatment of advanced gastric cancer].
Di Lauro L; Balice A; Carpano S; Papaldo P; Lopez M
Clin Ter; 1985 Dec; 115(5):361-4. PubMed ID: 3938357
[No Abstract] [Full Text] [Related]
6. cis-Dichlorodiammineplatinum(II) in the treatment of esophageal carcinoma.
Davis S; Shanmugathasa M; Kessler W
Cancer Treat Rep; 1980; 64(4-5):709-11. PubMed ID: 7191780
[TBL] [Abstract][Full Text] [Related]
7. [A study of preoperative administration of CDDP in 10 cases of esophageal carcinoma].
Shimizu H; Hosokawa M; Kawamura T; Komatsu M; Kanno N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):735-7. PubMed ID: 3827262
[No Abstract] [Full Text] [Related]
8. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
Bazarbashi S; Abdelsalam M; Amin T; El-Bassiouni M; Soudy H; Elweshi A; Alhusseiny H; Rehman K; Memon M; Ajarim D
Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ
Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of etoposide in the treatment of esophageal carcinoma.
Coonley CJ; Bains M; Heelan R; Dukeman M; Kelsen DP
Cancer Treat Rep; 1983 Apr; 67(4):397-8. PubMed ID: 6850656
[No Abstract] [Full Text] [Related]
12. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
13. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research.
Levard H; Pouliquen X; Hay JM; Fingerhut A; Langlois-Zantain O; Huguier M; Lozach P; Testart J
Eur J Surg; 1998 Nov; 164(11):849-57. PubMed ID: 9845131
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study.
Panettiere FJ; Leichman LP; Tilchen EJ; Chen TT
Cancer Treat Rep; 1984; 68(7-8):1023-4. PubMed ID: 6540144
[No Abstract] [Full Text] [Related]
16. [Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus].
Huang J; Cai RG; Meng PJ; Zhang MJ; Cui CX; Yang L; Chu DT; Sun Y; Wang JW
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):753-5. PubMed ID: 15733398
[TBL] [Abstract][Full Text] [Related]
17. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
Abdelghani L; Modha K; Albaddawi E; Subramanian S
J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
[No Abstract] [Full Text] [Related]
18. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma.
Gao XS; Qiao XY; Yang XR; Asaumi J; Zhou ZG; Wang YD; Zhou DA; Wan J; Kuroda M; Kishi K; Kawasaki S; Hiraki Y
Oncol Rep; 2002; 9(4):767-72. PubMed ID: 12066206
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
20. [Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].
Bedenne L; Seitz JF; Milan C; Renard P; Fraisse J; Conroy T; Lacourt J; Janoray P; Faivre J
Gastroenterol Clin Biol; 1998 Mar; 22(3):273-81. PubMed ID: 9762210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
